Phosphodiesterase 9 Inhibition as Treatment for Obesity-Related Conditions

Cardiac myosin light chain kinase-specific antibodies and methods of detecting

Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3

MANF2 for treatment of Parkinson's disease

RNA interference mediating small RNA molecules

Diagnostic and Therapeutic Use of the Kcne4 Gene and Protein for Alzheimer's Disease

Ant2 Conditional Knockout Mouse and Methods

DIABETES GENE

Methods and compounds to alter virus infection

Materials and methods relating to improved vaccination strategies

Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of a nematode gene

Animal Model for Studying Atherosclerotic Lesions

Regulation of mink in thymocytes and T lymphocytes

Antibodies to JTT-1 protein and cells secreting such antibodies

Transgenic Frog Lines and Assays Employing Them

Animal models of pancreatic adenocarcinoma and uses therefor

Inhibiting Gene Expression with dsRNA

Fibroblast growth factor (FGF23) polypeptides

Ph INTERACTING PROTEIN AND USE TO DIAGNOSE AND TREAT CANCER

Uses of human monoclonal antibodies against oxidized LDL receptor

Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity

ANTAGONIZING INTERLEUKIN-21 RECEPTOR ACTIVITY

Transgenic mammals having human IG loci including plural Vand Vregions and antibodies produced therefrom

Compositions and methods for increasing bone mineralization

Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof

sFRP expression enhancing agent

Polypeptide, novel DNA and novel antibody

Vectors having both isoforms of beta-hexosaminidase and uses of the same

Transgenic non-human animal for use in research models for studying Parkinson's disease

Inhibiting Gene Expression with dsRNA

Animal model for cancer, methods of producing the same and associated methods of use

NOVEL C. ELEGANS P21-ACTIVATED KINASE (PAK) GENE AND ASSOCIATED LOSS-OF-FUNCTION PHENOTYPES THAT FACILITATE SCREENING FOR SMALL MOLECULE MODULATORS OF PAK ACTIVITY IN THE NEMATODE, CAENORHABDITIS ELEGANS

Growth Differentiation Factor-8

Methods and compositions for using zinc finger endonucleases to enhance homologous recombination

Compositions and methods for modulating S-nitrosoglutathione reductase

Novel Polypeptides, and Nucleic Acids Encoding the Same

Treatment of Pompe's disease

Mouse in which genome is modified

Transgenic mouse whose genome comprises a homozygous disruption of its α1G gene, a method of preparing the same and use thereof

Splicing Variant of TGF-beta2 and Uses Thereof

GRP94-BASED COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS

Genetically engineered and phenotyped mice and stem cell clones for producing the same

Screening Method With The Use Of TBK1 Knockout Mouse

Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their use

DISEASE MODEL ANIMALS OF METABOLIC SYNDROME AND A METHOD OF SCREENING PREVENTIVE AND THERAPEUTIC AGENTS FOR METABOLIC SYNDROME USING THE SAME

Compositions and methods for increasing bone mineralization

SCHIZOPHRENIA ASSOCIATED GENES, PROTEINS AND BIALLELIC MARKERS

Method of modulating Sost binding to LRP

Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer

Growth Differentiation Factor-8 Nucleic Acid and Polypeptide from Aquatic Species, and Transgenic Aquatic Species

Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof

Methods of detecting prostate cancer using BAP28-related biallelic markers

Nonhuman model animal lacking the ability to control lymphocyte migration

Methods and Compositions for Using Tsh in the Inhibition of Tnf Activity

Culturing human cells and tissues in an N-glycolylneuraminic acid-free environment

Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited

Nonhuman model animal lacking the ability to control lymphocyte migration

Transgenic animals for assessing drug metabolism and toxicity

Chromosomal loci for the stringent control of gene activities via transcription activation systems

Composition For Screening Anti-Hypertension Drug Comprising Mammal Tctp Gene or Its Protein Product, and Method For Screening Anti-Hypertension Drug Using Said Composition

Methods for Inhibiting Melanocyte Stem Cell Loss

Compositions and methods for modulation of KSR1 and KSR2 interactions

RNA sequence-specific mediators of RNA interference

ROLE OF p62 IN AGING-RELATED DISEASE

Method for Inducing Mammary Epithelial Cell Differentiation

MOUSE CYTOKINE RECEPTOR ZCYTOR16

TREATMENT OF NEURODEGENERATIVE DISEASES AND CONDITIONS USING PAR1 ANTAGONISTS

Gene disruptions, compositions and methods relating thereto

Transgenic Animal Models for Neurodevelopmental Disorders

Method for treatment and prevention of ultraviolet light induced skin pathologies

Methods and means for increasing resistance to cell damage

DIAGNOSTICS AND THERAPEUTICS FOR ARTERIAL WALL DISRUPTIVE DISORDERS

Mammalian genes involved in infection

Drugs For Diseases Accompanying Changes In Total Bile Acid Pool Or Lipid Metabolism Disorders And Method Of Screening These Drugs

SAPAP3 knockout mouse and clinical modeling associated with the SAPAP3 gene

DISEASE MODEL ANIMALS OF METABOLIC SYNDROME AND A METHOD OF SCREENING PREVENTIVE AND THERAPEUTIC AGENTS FOR METABOLIC SYNDROME USING THE SAME

CISD2-Knockout Mice and Uses Thereof

Transgenic mammals having human Ig loci including plural Vand V regions and antibodies produced therefrom

Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis

Toll/Interleukin-1 receptor adapter protein (TIRAP)

SPHINGOSINE-1-PHOSPHATE LYASE POLYPEPTIDES, POLYNUCLEOTIDES AND MODULATING AGENTS AND METHODS OF USE THEREFOR

Control of NK cell function and survival by modulation of SHIP activity

Control Of Diabetes And Obesity

Human DRG11-responsive axonal guidance and outgrowth of neurite (dragon) proteins and variants thereof

Methods and Compositions Relating to Lipid Accumulation

Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions

Regulation of oncogenesis by Akt-specific isoforms

Phospholipase C β1 (PLCβ1) knockout mice as a model system for testing schizophrenia drugs

Modified Cells and Methods of Using Same

Prevention of primary sjogren' s Syndrome by ICA69 deficiency

METHODS AND COMPOSITIONS FOR TARGETING RELT

Mouse model of cholinergic dysfunction to evaluate cognitive enhancers and drugs that improve myasthenia

TRPS1-mediated modulation of hair growth

Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them

Grp Receptor-Related Methods for the Treating and Preventing Fear-Related Disorders

Nonhuman model animal of Th2-mediated hyperimmune response

Transformed cell harboring DNA or RNA encoding sugar chain synthesizing agent having β1,3-N-acetylglucosaminyltransferase activity

INHIBITION OF ALPHA-2 HS GLYCOPROTEIN (AHSG/FETUIN) IN OBESITY AND INSULIN CONTROL OF GLUCOSE HOMEOSTASIS

Retinal dystrophin transgene and methods of use thereof

Method of Suppressing Cancer

Animal model of neurodegenerative diseases, the procedure for producing the model and applications thereof

MODEL FOR NEURODEGENERATIVE DISEASES INVOLVING AMYLOID ACCUMULATION

Fluid flow meter body with high immunity to inlet/outlet flow disturbances

Method for rendering a system immunologically compatible utilizing a nucleic acid construct, a nucleic acid construct for inhibiting or regulating the function of an immune response (Ir) gene and an immunologically compatible system containing a nucleic acid construct for inhibiting or regulating the function of an immune response (Ir) gene

Knockout Non-Human Animal

Use of VEGF and homologuest to treat neuron disorders

Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9, alpha2delta-4, 8099, 46455, 54414, 53763, 97076, 97102, 44181, 67084Fl and 67084alt molecules and uses therefor

Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene

Method of proliferation in neurogenic regions

Ungulates with genetically modified immune systems

Method of diagnosing lung cancer using BGS42

Uses of Sperm Membrane Protein Obf

Permeability of blood-brain barrier

MICE LACKING ALPHA 1G SHOWING ENHANCED NOVELTY-SEEKING AND ALCOHOL PREFERENCE AND THERAPEUTIC METHODS FOR MOOD DISORDERS BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS

Transgenic mice carrying functional single nucleotide polymorphisms in brain-specific tryptophan hydroxylase

Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal

Screening methods for compounds useful in the regulation of body weight

Methods for Relieving Neuropathic Pain by Modulating Alpha1G T-Type Calcium Channels and Mice Lacking Alpha 1G T-Type Calcium Channels

MAVS in the prevention and treatment of viral diseases

Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer

Compositions and methods for treating kidney disease

Methods for Identifying Treatment and Inducing Infertility Using Smc1-Beta

IDENTIFICATION OF SES-3 AND THE USES OF SAME

Chimeric cancer models

Antibodies that specifically bind SOST peptides

PRO224 gene disruptions, and methods related thereto

Method for testing a compound for a therapeutic effect and a diagnostic method

Ornithine aminotransferase (OAT): a target for anticancer drugs

Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof

Animal Selected For Lacking Heparan Sulfate-3-O-Sulfotransferase-1 and Uses Thereof

Methods of Identifying Compounds Which Modulate Granulocite-Colony Stimulating Factor (G-Csf) Dependent Processes by Modulation of the Levels of Suppressor of Cytokine Signaling (Socs)

Methods of modifying genes in eukaryotic cells

Cloning B and T lymphocytes

Human kinases and polynucleotides encoding the same, and uses thereof

Use of Caspase-8 Inhibitors for Modulating Hematopoiesis

KSR2 knockout mice and methods of use thereof

PRO1477 polypeptides

Human hemojuvelin (HJV) or dragon-like 1 (DL-1) polypeptides and variants and uses thereof

Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity

Methods and compositions for recovering or improving visual function

Dep2 and its uses in major depressive disorder and other related disorders

Construction of Chimera Using En Cells

VEGF Receptor Conditional Knockout Animals and Methods of Use

Mannose binding lectin knock-out mice and methods of use thereof

Modulation of immune response and inflammation by targeting hypoxia inducible factors

Use of VEGF and homologues to treat neuron disorders

Use of the receptor GPR86

Method for preventing or treating neuropathic pain

IN VIVO ALTERATION OF CELLULAR DNA

O-GLYCANS IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND CANCERS

METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS

Functional antibodies that specifically bind to the Chemerin receptor

PRO4356 polypeptides

Methods for use of TSLP and agonists and antagonists thereof

GDF-9/BMP-15 modulators for the treatment of bone disorders

Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascualr disorders

Hemojuvelin or dragon-like 2 (DL-2) polypeptides and variants and uses thereof

Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders

Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer

Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure

32263, a novel human biotin enzyme and uses thereof

Cell and transgenic animal modelling human antigenic presentation and their uses

Interleukins-21 and 22

Transgenic animals and methods of monitoring hedgehog responding cells

Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation

Methods of constructing a gene mutation library and compounds and compositions thereof

31 Human Secreted Proteins

Muscle regeneration compositions and uses therefor

Diabetes treatment methods and drug targets therefor

Knockout mouse for the tumor suppressor gene ANX7

Screen for pre-eclampsia

Method of promoting delivery of an antioxidant agent to a cell expression neuroligin

Transgenic mice containing TRP gene disruptions

Methods for treating conditions associated with MASP-2 dependent complement activation

Interleukins-21 and 22

Methods and compositions for modulating gamete adhesion

Ion channel

Transgenic mice containing Lrp5 gene disruptions

Methods and compositions for treating motor neuron associated disorders

Stars—A muscle-specific actin-binding protein

Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases

In vivo odorant receptor systems and their uses

TNF-like secreted protein

BLOCKING LEUKOCYTE EMIGRATION AND INFLAMMATION BY INTERFERING WITH CD99/HEC2

Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

SPC7 Serine Protease Gene Disruptions, Compositions and Methods Related Thereto

Mutation in the rat adenomatous polyposis coli gene within the human mutation hotspot region

Genes encoding several poly (ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith

Follistatin isoforms and uses thereof

Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases

Methods and compositions for inhibition of immune responses

Method of modulating fertility in animals

Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo

Disruptions in GABA Receptor RHO2 Subunit, Methods and Uses Thereof

Invertebrate animal model with neurodegenerative phenotype for screening and testing substances

Compositions and methods for the treatment of cancer

Methods for controlling pathological angiogenesis by inhibition of a6b4 integrin

Antibodies against epitopes with homology to self antigens, methods of preparation

Transgenic mice carrying the HP-2 gene and uses as models for vascular diseases

Ion channel

Transgenic non-human animals for pharmacological and toxicological studies

Methods and means for inhibiting fever

Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecles, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor

Medicament comprising inhibitors of long pentraxin ptx3

RNA interference mediating small RNA molecules

Histone deacetylases, and uses related thereto

PRO1298 polypeptides

Proton-sensing g-protein coupled receptors and dna sequences thereof

Modified organs and cells for xenotransplantation

Rab9a, rab11a, and modulators thereof related to infectious disease

Rat TRPM7 polynucleotide and encoded protein

Method for screening PTPzeta activity promoter or inhibitor

Transgenic Mice Containing GPCR5-1 Gene Disruptions

TAAR1 knock out animal

Isolated INSP 163 protein

Double-muscling in mammals

Production of human glycosylated proteins in transgenic insects

Mammalian IAP gene family, primers, probes and detection methods

Mammalian sour/acid taste and CSF receptor genes, polypeptides and assays

IL-17 receptor like molecules and uses thereof

26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor

Inhibitor of differentiation knockout mammals and methods of use thereof

Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer

Therapeutiv preparation for hematopoietic disease

Model for muscular dystrophy and cardiomyopathy

Compositions and methods of using angiopoietin-like 4 protein

Tumor suppressor designated TS10Q23.3

Hedgehog interacting proteins and uses related thereto

Modulation of s6 kinase activity for the treatment of obesity

Method of treatment and prophylaxis

Tumor suppressor designated TS10q23.3

Mammalian IAP gene family, primers, probes and detection methods

P2Y4 Receptor transgenic and knockout non-human mammals

Gp131: methods and compositions for treating cancer

Mammalian IAP gene family, primers, probes and detection methods

Dendritic Enriched Secreted Lymphocyte Activation Molecule

Apo-2DcR

Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

Goodpasture's syndrome model mouse

Methods for modulating transcriptional activation using mint proteins

Methods of modulating bone growth, bone remodeling and adiposity

Semaphorin gene family

Using cytosine deaminases to diminish retroelement transfer from pigs to humans

ES cells having enhanced RNAi effect

Human secreted proteins

Mammalian IAP gene family, primers, probes and detection methods

Mammalian IAP gene family, primers, probes and detection methods

G-protein coupled receptor and uses therefor

Uses for Eph receptor antagonists and agonists

Transgenic non-human Act1-deficient mammals and uses thereof

Mammalian IAP gene family, primers, probes and detection methods

Mammalian IAP gene family, primers, probes and detection methods

Mammalian IAP gene family, primers, probes and detection methods

HUNTINGTIN INTERACTING PROTEIN GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO

Proliferator-Activated Receptor Disruptions, Compositions and Methods Relating Thereto

Methods and compositions for detecting cancers

NPC1L1 (NPC3) and methods of use thereof

Model of autoimmune disease and methods for identifying agents against autoimmune disease

Guinea pig-chymase

Nonhuman model animal suffering from Guillain-Barré syndrome and/or fisher syndrome

Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation

Mouse with deficiency of glutamate transporter GLAST function

Lysosomal proteins produced in the milk of transgenic animals

Mammalian IAP gene family, primers, probes, and detection methods

Method of identifying activity modulators of a polycystin-2L1 taste receptor polypeptide

Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

RNA sequence-specific mediators of RNA interference

Inhibition of the β3 subunit of L-type Cachannels

Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor

Mo54 Disruptions, Compositions and Methods Related Thereto

WIP, a WASP-associated protein

Alpha1-3 galactosyltransferase gene and promoter

Novel haemopoietin receptor and genetic sequences encoding same

Compositions, organisms and methodologies employing a novel human kinase

Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure

Anti-viral activity of cathelicidin peptides

SCREENING SYSTEMS AND METHODS FOR IDENTIFYING MODULATORS OF XENOBIOTICMETABOLISM

CD9/CD81 double-deficient non-human animal

Artery-and vein-specific proteins and uses therefor

Genetic screen in drosophila for metastatic behavior

Aortic carboxypeptidase-like polypeptide

Nucleic acid molecules and polypeptides for immune modulation

Mediators of epithelial adhesion and their role in cancer and skin disorders

Methods for treating demyelination disorders

Functional characterization of myo-inositol monophosphatase

Compositions and Methods for Making Embryonic Stem Cells

Splice variant of the human pituitary growth hormone

Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome

Cathepsin G (CTSG) Disruptions, Compositions and Methods Relating Thereto

Screening method with the use of TBK1 knockout mouse

Method of diagnosis of obesity

Method of diagnosing testicular tumors using polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42

Transgenic mice containing glutamate receptor (GRIK5) gene disruptions

Gab2 (p97) gene and methods of use thereof

Animals with reduced body fat and increased bone density